 | Up a level |
Dal Pra, A.; Ghadjar, P.; Hayoz, S.; Spratt, D.E.; Liu, V.Y.; Todorovic, T.; Davicioni, E.; Huang, H.C.; Schär, C.; Hölscher, T.; Gut, P.; Polat, B.; Hildebrandt, G.; Mueller, A.C.; Plasswilm, L.; Thalmann, G.; Zwahlen, D.R.; Aebersold, D.M. (2021). Performance of a Genomic Classifier (GC) Within a Phase 3 Randomized Trial of Dose Escalated Salvage Radiotherapy (SRT) After Radical Prostatectomy (RP). International journal of radiation oncology, biology, physics, 111(3, Suppl. 1), S49-S50. Elsevier 10.1016/j.ijrobp.2021.07.132
Beck, M.; Sassowsky, M.; Schär, S.; Mathier, E.; Halter, M.; Zwahlen, D.R.; Hoelscher, T.; Arnold, W.; Polat, B.; Hildebrandt, G.; Mueller, A.C.; Putora, P.; Papachristofilou, A.; Sumila, M.; Zaugg, K.; Guckenberger, M.; Ost, P.; Aebersold, D.; Ghadjar, P. and Dal Pra, A. (24 October 2020). Contouring quality and adherence to EORTC-based protocol guidelines in the randomized phase III SAKK 09/10 trial for postoperative prostate cancer radiotherapy: Implications for treatment quality and future clinical trials (Unpublished). In: ASTRO Annual Meeting.
